{{Infobox scientist
| name              = Nicholas Lydon
| image             = Nicholas Lydon.jpg
| image_size        = 
| alt               = 
| caption           = 
| birth_date        = {{Birth date and age|1957|2|27}} 
| birth_place       = 
| death_date        = <!-- {{Death date and age|YYYY|MM|DD|YYYY|MM|DD}} (death date then birth date) -->
| death_place       = 
| residence         = 
| citizenship       = 
| nationality       = 
| fields            = 
| workplaces        = [[安进|安进]]
| alma_mater        = [[利兹大学|利兹大学]]、[[邓迪大学|邓迪大学]]
| doctoral_advisor  = 
| academic_advisors = 
| doctoral_students = 
| notable_students  = 
| known_for         = [[格列卫|格列卫]]
| author_abbrev_bot = 
| author_abbrev_zoo = 
| influences        = 
| influenced        = 
| awards            = [[拉斯克奖|拉斯克奖]] (2009)
| signature         = <!--(filename only)-->
| signature_alt     = 
| footnotes         = 
| spouse            = 
}}'''尼古拉斯·B·莱登'''（{{lang-en|'''Nicholas B. Lydon'''}}，{{bd|1957年|2月27日}}），英国科学家、企业家。他因研发[[格列卫|格列卫]]——一种治疗[[慢性粒细胞白血病|慢性粒细胞白血病]]的选择性BCR - ABL抑制剂获得2009年[[拉斯克奖|拉斯克奖]]。<ref>{{cite web|url=http://www.laskerfoundation.org/awards/2009_c_description.htm|title=Lasker - DeBakey Clinical Medical Research Award: Award Description|publisher=Lasker Foundation|accessdate=16 August 2010}}</ref>莱登在英国[[利兹大学|利兹大学]]获生物化学理学士，在[[邓迪大学|邓迪大学]]获得博士学位。

== 参考资料 ==
{{reflist}}

{{日本国际奖获得者}}
{{拉斯克-德贝基临床医学研究奖获得者}}
[[Category:英国生物化学家|L]]
[[Category:日本国际奖获得者|L]]
[[Category:里兹大学校友|L]]
[[Category:鄧地大學校友|L]]
[[Category:拉斯克临床医学研究奖获得者|Category:拉斯克临床医学研究奖获得者]]